Consistent with the data obtained in SLE patients, in previous studies, we found a significant prevalence of anti-IFI16 antibodies in SSc, which was more evident in the more benign limited cutaneous form of this disease (42). This evidence concerns the gene IFI16 and systemic lupus erythematosus.